BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17509907)

  • 1. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Pax5 promotes plasma cell differentiation.
    Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
    Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
    Lin KI; Angelin-Duclos C; Kuo TC; Calame K
    Mol Cell Biol; 2002 Jul; 22(13):4771-80. PubMed ID: 12052884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms that determine the development and function of plasma cells.
    Calame KL; Lin KI; Tunyaplin C
    Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected steps in plasma-cell differentiation.
    Klein U; Dalla-Favera R
    Immunity; 2007 May; 26(5):543-4. PubMed ID: 17521580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.
    Sciammas R; Shaffer AL; Schatz JH; Zhao H; Staudt LM; Singh H
    Immunity; 2006 Aug; 25(2):225-36. PubMed ID: 16919487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion.
    Savitsky D; Calame K
    J Exp Med; 2006 Oct; 203(10):2305-14. PubMed ID: 16954370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene.
    Fairfax KA; Corcoran LM; Pridans C; Huntington ND; Kallies A; Nutt SL; Tarlinton DM
    J Immunol; 2007 Apr; 178(7):4104-11. PubMed ID: 17371965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
    Angelin-Duclos C; Cattoretti G; Lin KI; Calame K
    J Immunol; 2000 Nov; 165(10):5462-71. PubMed ID: 11067898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
    Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
    J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.
    Kallies A; Hasbold J; Tarlinton DM; Dietrich W; Corcoran LM; Hodgkin PD; Nutt SL
    J Exp Med; 2004 Oct; 200(8):967-77. PubMed ID: 15492122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice.
    Zhou Z; Li A; Wang Z; Pei F; Xia Q; Liu G; Ren Y; Hu Z
    Hum Immunol; 2013 Mar; 74(3):297-301. PubMed ID: 23220434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.
    Yasuda T; Hayakawa F; Kurahashi S; Sugimoto K; Minami Y; Tomita A; Naoe T
    J Immunol; 2012 Jun; 188(12):6127-34. PubMed ID: 22593617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirement for OBF-1 during antibody-secreting cell differentiation.
    Corcoran LM; Hasbold J; Dietrich W; Hawkins E; Kallies A; Nutt SL; Tarlinton DM; Matthias P; Hodgkin PD
    J Exp Med; 2005 May; 201(9):1385-96. PubMed ID: 15867091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch.
    Muto A; Ochiai K; Kimura Y; Itoh-Nakadai A; Calame KL; Ikebe D; Tashiro S; Igarashi K
    EMBO J; 2010 Dec; 29(23):4048-61. PubMed ID: 20953163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding B Cells via Multiple Molecular Pathways.
    Basu S; Kaw S; D'Souza L; Vaidya T; Bal V; Rath S; George A
    J Immunol; 2016 Aug; 197(3):761-70. PubMed ID: 27342845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
    Borson ND; Lacy MQ; Wettstein PJ
    Blood; 2002 Dec; 100(13):4629-39. PubMed ID: 12453881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.